COVID-19 Research And Innovation

Some of Vanderbilt University’s leading experts on vaccines, infectious disease and public health came together for a special panel discussion on March 10 to talk about the future of the COVID-19 pandemic. The virtual event, “The COVID Conundrum: What’s Next,” was hosted by the Chancellor’s Lecture Series in partnership with the Vanderbilt School of Medicine Basic Sciences. Read More

Registration is now open for a special panel discussion about the future of COVID-19, featuring some of Vanderbilt University’s leading experts in COVID vaccines, infectious disease and public health. The virtual discussion will be on Thursday, March 10, at noon CT. Read More

The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read More

The first holistic review of older adult care operations sheds light on opportunities for industry reform. Est. reading time: 2.5 mins. Read More

Carl Johnson, Cornelius Vanderbilt Professor of Biological Sciences and expert in biological clocks, identifies temporal component to COVID-19 viral shedding. Est. reading time: 2.5 mins. Read More

A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. Read More

National and local leaders who played key roles in the original rollout and current support of the COVID-19 vaccine came together for a panel, “Vaccine Hesitancy: The Politics of Public Health in Tennessee,” hosted by The Vanderbilt Project on Unity and American Democracy and Vanderbilt University Medical Center Aug. 18. Read More

The Center for Technology Transfer and Commercialization continued to play a pivotal role in translating the research findings of Vanderbilt faculty into products and companies in 2020 that have the potential to transform many aspects of life, from disease prevention to quality of life-enhancing products. Read More

The Vanderbilt Kennedy Center will host a Research Ethics Grand Rounds panel discussion, "Standards of Care, Disability and a Public Health Emergency: Conversations on Equitable Care during COVID-19," on Wednesday, May 19, from noon to 1 p.m. CT. Read More

Dr. James E. Crowe Jr., a physician-scientist on the front lines of global research to eliminate human susceptibility to COVID-19 and other illnesses, is Vanderbilt University’s winner of the 2021 Southeastern Conference Faculty Achievement Award. Read More

Vanderbilt’s role in shaping each step of the medical response to the COVID-19 pandemic began three decades ago and is grounded in the determination of a small group of scientists to understand coronaviruses. The research, and the faculty and alumni who helped lead it, was the topic of the March 23 Chancellor’s Lecture Series virtual event, “Vanderbilt in the Vanguard: The Decades-Long Journey to a Coronavirus Vaccine.” Read More

The remarkable success of the COVID-19 vaccines began in a Vanderbilt lab decades ago, with the groundbreaking research of alumnus Dr. Barney Graham. Read More

Vanderbilt scientists on the front lines of COVID-19 research will share their insights on the pandemic and subsequent vaccine development during a Chancellor’s Lecture Series event on Tuesday, March 23, at 5 p.m. CT, hosted by Chancellor Daniel Diermeier. Read More

During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. The efforts of Peabody College's James Booth and the College of Arts and Science's Katherine Friedman are highlighted. Read More

Christina D. Romer, the Class of 1957-Garff B. Wilson Professor of Economics at the University of California–Berkeley, will discuss “The Macroeconomic Policy Response to the Pandemic: The Good, the Bad and the Ugly” on Tuesday, March 9, beginning at 4 p.m. CT. Her virtual talk is the spring 2021 McGee Public Policy Lecture sponsored by the Department of Economics. Read More

During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. The efforts of the School of Medicine Basic Science's Danny Winder and the School ofEngineering's Ethan Lippmann are highlighted. Read More

Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. Read More

In January 2020, the accelerating spread of SARS-CoV-2 made it apparent that VUMC’s two-bed Contagious Disease Response Unit, created for the rare victim of Ebola or other more-isolated emerging pathogen, would not suffice if Nashville were to be hit hard. So administrators began planning for a major outbreak. Read More

Vanderbilt first-year students recently met with Buddy Creech, director of the Vanderbilt Vaccine Research Program and associate professor of pediatrics, for a special virtual chat to answer some of their COVID-19 vaccine questions. Read More

The Vanderbilt Diabetes Center, the NIH-funded Diabetes Research and Training Center, and the NIH-funded Center for Diabetes Translational Research seek pilot and feasibility proposals to study the interaction of SARS-CoV-2/COVID-19 and diabetes. Read More